• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.

作者信息

Herion D, Hoofnagle J H

出版信息

Hepatology. 1997 Mar;25(3):769-71. doi: 10.1002/hep.510250346.

DOI:10.1002/hep.510250346
PMID:9049233
Abstract
摘要

相似文献

1
The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.干扰素敏感性决定区：并非所有丙型肝炎病毒分离株都相同。
Hepatology. 1997 Mar;25(3):769-71. doi: 10.1002/hep.510250346.
2
Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon.丙型肝炎病毒2a和2b基因型非结构区5A中的氨基酸替换及其与病毒载量和干扰素反应的关系。
Am J Gastroenterol. 2002 Apr;97(4):988-98. doi: 10.1111/j.1572-0241.2002.05619.x.
3
Management of hepatitis C virus genotype 4.丙型肝炎病毒基因4型的管理
J Gastroenterol Hepatol. 2004 Nov;19(11):1233-9. doi: 10.1111/j.1440-1746.2003.03325.x.
4
Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?
Am J Gastroenterol. 2002 May;97(5):1093-6. doi: 10.1111/j.1572-0241.2002.05701.x.
5
Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma.丙型肝炎病毒1b型、肝硬化和肝细胞癌。
Hepatology. 1997 Mar;25(3):772-4. doi: 10.1002/hep.510250347.
6
Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.丙型肝炎病毒以及干扰素敏感性决定区在干扰素治疗反应中的争议性作用。
J Med Virol. 2008 Feb;80(2):247-53. doi: 10.1002/jmv.21060.
7
[Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):930-5.
8
Novel interferons for treatment of hepatitis C virus.用于治疗丙型肝炎病毒的新型干扰素。
Clin Liver Dis. 2009 Aug;13(3):351-63. doi: 10.1016/j.cld.2009.05.004.
9
Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.1b型丙型肝炎病毒感染且病毒载量高的患者对干扰素-利巴韦林联合治疗病毒学无应答的预测因素
J Med Virol. 2006 Jan;78(1):83-90. doi: 10.1002/jmv.20507.
10
Hepatitis C virus: prospects for future therapies.丙型肝炎病毒：未来治疗前景
Curr Opin Investig Drugs. 2001 Nov;2(11):1516-22.

引用本文的文献

1
Mutations around interferon sensitivity-determining region: a pilot resistance report of hepatitis C virus 1b in a Hong Kong population.干扰素敏感性决定区周围的突变：香港人群中丙型肝炎病毒 1b 的耐药性初步报告。
World J Gastroenterol. 2011 Dec 28;17(48):5317-23. doi: 10.3748/wjg.v17.i48.5317.
2
Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin.干扰素联合利巴韦林治疗前后丙型肝炎病毒的基因变异性
PLoS One. 2008 Aug 26;3(8):e3058. doi: 10.1371/journal.pone.0003058.
3
Nonresponse to treatment for hepatitis C: current management strategies.
丙型肝炎治疗无应答：当前的管理策略
Drugs. 2008;68(1):27-42. doi: 10.2165/00003495-200868010-00003.
4
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C.慢性丙型肝炎患者干扰素与利巴韦林联合治疗的预测因素
World J Gastroenterol. 2007 Dec 14;13(46):6236-42. doi: 10.3748/wjg.v13.i46.6236.
5
Replicative homeostasis III: implications for antiviral therapy and mechanisms of response and non-response.复制性稳态III：对抗病毒治疗的影响以及应答和无应答机制
Virol J. 2007 Mar 13;4:29. doi: 10.1186/1743-422X-4-29.
6
The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India.丙型肝炎病毒NS5A蛋白与α干扰素反应：来自印度的慢性丙型肝炎3a基因型感染患者的突变分析
Med Microbiol Immunol. 2007 Mar;196(1):11-21. doi: 10.1007/s00430-006-0024-z. Epub 2006 Sep 6.
7
Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences.通过NS5A-ISDR内的突变数量预测1b型丙型肝炎病毒感染患者的持续病毒学应答：一项关注地理差异的荟萃分析
Gut. 2004 Sep;53(9):1345-51. doi: 10.1136/gut.2003.031336.
8
Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C.干扰素 alfacon-1：其治疗慢性丙型肝炎的药理学及治疗效果综述
Drugs. 2001;61(11):1661-91. doi: 10.2165/00003495-200161110-00009.
9
Selection of HCV NS5A quasispecies during IFN therapy in patients with chronic HCV.
Dig Dis Sci. 2001 Jul;46(7):1399-408. doi: 10.1023/a:1010623417345.
10
Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.丙型肝炎病毒非结构5A蛋白诱导白细胞介素-8，导致干扰素诱导的抗病毒反应部分受到抑制。
J Virol. 2001 Jul;75(13):6095-106. doi: 10.1128/JVI.75.13.6095-6106.2001.